NASDAQ : ALTO
-$0.43 (-7.65%)
| Source | Headline |
|---|---|
|
Can Debottlenecking Drive Alto Ingredients' Next Growth Phase?
ALTO is pursuing a targeted plant upgrade to boost production, improve efficiency and capture more clean fuel tax benefits. zacks.com - 2026-07-13 11:51:09 |
|
Can Alto Ingredients Sustain Its Return to Profitability Momentum?
ALTO's first-quarter 2026 return to profitability reflects stronger exports, higher crush margins, richer product mix and operating improvements. zacks.com - 2026-07-06 10:21:17 |
|
4 Consumer Products Discretionary Stocks Investors Must Buy in H2 2026
CENT, ALTO, LCUT and ACCO are poised to outperform in the second half of 2026 with strong brands, innovation and strategic execution. zacks.com - 2026-07-03 09:55:31 |
|
Alto Ingredients, Inc. (ALTO) Hits Fresh High: Is There Still Room to Run?
Alto Ingredients (ALTO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com - 2026-07-02 10:16:06 |
|
Why Alto Ingredients Is Expanding Pekin Production Capacity
ALTO is expanding its Pekin dry mill to boost production, improve efficiency and strengthen profitability through operational upgrades. zacks.com - 2026-07-02 09:11:15 |
|
Can Biogenic CO2 Become Alto Ingredients' Next Growth Business?
ALTO is building a growth opportunity around biogenic CO2 through expanded storage capacity and potential Section 45Z tax-credit benefits. zacks.com - 2026-06-29 12:21:07 |
|
Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?
Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year. zacks.com - 2026-06-29 10:40:38 |
|
Alto Ingredients, Inc. Added to Russell 2000® and Russell 3000® Indexes
PEKIN, Ill., June 29, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols, today announced it has been added to the Russell 2000® and Russell 3000® Indexes, effective after the close of U.S. markets on Friday, June 26, 2026. globenewswire.com - 2026-06-29 08:30:00 |
|
Alto Ingredients vs. Green Plains: Which Stock Offers More Upside?
ALTO and GPRE are pursuing different biofuel strategies as ethanol producers navigate corn prices, policy shifts and low-carbon demand. zacks.com - 2026-06-26 10:10:28 |
|
Alto Ingredients: A Profitable Turnaround In Progress With Upside Potential
Alto Ingredients is executing a successful turnaround, shifting to a leaner, more resilient business model with improved profitability and operational focus. Q1 2026 results highlighted strong profitability, robust crush margins, and material contributions from Section 45Z tax credits, supporting sustainable earnings momentum. ALTO's valuation, growth, and momentum metrics significantly outperform sector medians, with 482% 1-year price performance and EBITDA growth of 696% YoY. seekingalpha.com - 2026-06-25 09:56:38 |
|
ALTO Announces Full-Building Lease With a Major 3rd Party Logistics Company at ALTO Pinto 45
DALLAS--(BUSINESS WIRE)--ALTO Real Estate Funds is pleased to announce the successful execution of a full-building lease with a major 3rd party logistics company at ALTO Pinto 45, a 586,919 SF Class A industrial facility in South Dallas. The lease marks a major milestone for the project, delivering 100% occupancy and securing a global logistics leader as the long-term tenant. With lease execution completed in May 2026 and operations expected to commence in August 2026, this transaction reinforc. businesswire.com - 2026-06-24 06:22:00 |
|
Why Alto Ingredients Is Earning More From Every Bushel of Corn
ALTO is earning more from each corn bushel as stronger co-product pricing and lower corn costs offset softer alcohol demand. zacks.com - 2026-06-22 12:25:35 |
|
ALTO Announces Full-Building Lease with DHL at ALTO Pinto 45
DALLAS--(BUSINESS WIRE)--ALTO Real Estate Funds is pleased to announce the successful execution of a full-building lease with DHL at ALTO Pinto 45, a 586,919 SF Class A industrial facility in South Dallas. The lease marks a major milestone for the project, delivering 100% occupancy and securing a global logistics leader as the long-term tenant. With lease execution completed in May 2026 and operations expected to commence in August 2026, this transaction reinforces the strength of the Dallas lo. businesswire.com - 2026-06-22 07:21:00 |
|
Alto Ingredients: This Small-Cap Turnaround Still Has Room To Run
Alto Ingredients has rallied more than 300% over the last year, but the stock still trades at a discount to the sector. Gross profit improved sharply year over year, helped by stronger crush margins, export demand, 45Z tax credits, and derivative gains. Scenario analysis shows ALTO trades at a 33–40% P/E discount to peers, with 2027 base and bull cases offering 73–98% upside; I rate it Strong Buy. seekingalpha.com - 2026-06-18 06:05:39 |
|
Alto Ingredients Stock Rises 374% in a Year: How to Play the Stock
ALTO has surged 374% in a year as improving profitability, Section 45Z credits and expansion projects boost optimism. zacks.com - 2026-06-16 11:15:31 |
|
Alto Ingredients Taps Into 45Z Credits: How Big Is the Opportunity?
ALTO is seeing new earnings opportunities from Section 45Z credits while investing to expand benefits over time. zacks.com - 2026-06-15 11:50:42 |
|
Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits
PEKIN, Ill., June 15, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that it has completed a sale transaction with a third-party corporate buyer for all of Alto Ingredients' 2025 Section 45Z Clean Fuel Production Tax Credits generated from its low-carbon ethanol production. globenewswire.com - 2026-06-15 08:30:00 |
|
New Strong Buy Stocks for June 15th
EZPW, PLOW, NVT, ALTO and SLQT have been added to the Zacks Rank #1 (Strong Buy) List on June 15, 2026. zacks.com - 2026-06-15 05:26:07 |
|
Best Value Stocks to Buy for June 15th
PEB, GDS and ALTO made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 15, 2026. zacks.com - 2026-06-15 03:56:05 |
|
Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?
Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year. zacks.com - 2026-06-12 10:41:16 |
|
4 Stocks With Solid Net Profit Margin to Strengthen Your Portfolio
FLXS, ARKO, SNEX and ALTO boast strong net margins, rising earnings and bullish analyst ratings that signal upside. zacks.com - 2026-06-10 10:11:15 |
|
New Strong Buy Stocks for June 10th
ALTO, FGI, CHGG, AAON and DAVE have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2026. zacks.com - 2026-06-10 05:41:04 |
|
Best Value Stocks to Buy for June 10th
ECPG, CMCO and ALTO made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 10, 2026. zacks.com - 2026-06-10 05:01:05 |
|
5 Broker-Adored Stocks to Watch in the Current Volatile Scenario
In oil-driven volatility, brokers favor ALTO, ARW, GPRE, AAL and ACDVF. These are screened for upgrades, estimate lifts and low P/S. zacks.com - 2026-06-08 13:21:06 |
|
How Strong Export Demand Boosted Alto Ingredients' Profitability
ALTO returns to profitability in the first quarter, with a favorable product mix helping offset operational challenges and seasonal market pressures. zacks.com - 2026-06-08 13:11:24 |
|
Best Momentum Stocks to Buy for June 8th
APPS, CAL, and ALTO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 8, 2026. zacks.com - 2026-06-08 11:16:04 |
|
Alto Ingredients (ALTO) is on the Move, Here's Why the Trend Could be Sustainable
Alto Ingredients (ALTO) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen. zacks.com - 2026-06-05 09:55:11 |
|
Alto Ingredients: A Strong Buy Stock With Positive Turnaround Themes
Alto Ingredients (ALTO) produces specialty alcohols for industry and is trading at a significant discount to sector medians, with forward EV/sales at 0.54x. ALTO's Q1 earnings beat expectations, with adjusted EBITDA swinging to $4.7M from a $4.4M loss, and gross profit rising to $9.2M from -$1.8M. Management is executing a turnaround strategy, improving essential ingredient returns, and planning a debottlenecking project to boost capacity by 8%. seekingalpha.com - 2026-06-04 04:13:23 |
|
Best Value Stocks to Buy for June 3rd
ALTO, BMA and GCO made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 3rd, 2026. zacks.com - 2026-06-03 07:16:09 |
|
How ALTO Is Benefiting From Stronger Essential Ingredients Returns
ALTO's essential ingredients return rises to 53.4% in Q1 2026, aided by higher co-product pricing and lower corn costs, even as volumes decline. zacks.com - 2026-06-02 12:01:34 |
|
Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?
Here is how Alto Ingredients (ALTO) and Hugo Boss (BOSSY) have performed compared to their sector so far this year. zacks.com - 2026-05-27 10:40:26 |
|
Alto Ingredients, Inc. to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
PEKIN, Ill., May 18, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced that management is scheduled to participate at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, in Minneapolis, MN. globenewswire.com - 2026-05-18 08:30:00 |
|
Best Momentum Stocks to Buy for May 15th
ALTO, LSCC and INTT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 15th, 2026. zacks.com - 2026-05-15 11:01:12 |
|
Alto Ingredients (ALTO) Upgraded to Strong Buy: Here's Why
Alto Ingredients (ALTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 2026-05-11 13:01:12 |
|
Best Momentum Stocks to Buy for May 11th
ALTO, STRL and LSCC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 11th, 2026. zacks.com - 2026-05-11 11:01:15 |
|
Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?
Here is how Alto Ingredients (ALTO) and Hugo Boss (BOSSY) have performed compared to their sector so far this year. zacks.com - 2026-05-11 10:40:45 |
|
Alto Ingredients, Inc. (ALTO) Q1 2026 Earnings Call Transcript
Alto Ingredients, Inc. (ALTO) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-07 03:41:32 |
|
Alto Ingredients (ALTO) Beats Q1 Earnings Estimates
Alto Ingredients (ALTO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.16 per share a year ago. zacks.com - 2026-05-06 19:35:52 |
|
Alto Ingredients, Inc. Reports First Quarter 2026 Results
Q1 2026 Gross Profit of $9.2 Million Increased $11.0 Million Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025 PEKIN, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026. globenewswire.com - 2026-05-06 16:05:00 |
|
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 (formerly CTC-501) in patients with Major Depressive Disorder (MDD). The data were presented in a poster session at the 2026 Annual Meeting of the Society of Biological Psychiatry (SOBP). ALTO-20. businesswire.com - 2026-05-04 08:03:00 |
|
Recent Price Trend in Alto Ingredients (ALTO) is Your Friend, Here's Why
Alto Ingredients (ALTO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. zacks.com - 2026-04-30 09:56:07 |
|
Alto Ingredients, Inc. to Release First Quarter 2026 Financial Results on May 6, 2026
PEKIN, Ill., April 30, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced it will release its first quarter 2026 financial results after the close of market on Wednesday, May 6, 2026. globenewswire.com - 2026-04-30 08:30:00 |
|
Alto Ingredients Going Full Soprano
Alto Ingredients has rebounded over 300% since 2023, driven by operational turnaround and strategic execution after a period of severe headwinds. Cost reductions, the accretive Alto Carbonic acquisition, and the ability to earn 45z credits have transformed ALTO's earnings power and margin profile. Exporting renewable fuel at premium prices has become a structural earnings driver, with forward contracts secured into 2026 and with accelerating volumes. seekingalpha.com - 2026-04-26 21:02:13 |
|
Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?
Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year. zacks.com - 2026-04-24 10:41:29 |
|
Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the initiation of a Phase 2b randomized, placebo-controlled trial of ALTO-207 in treatment-resistant depression (TRD), a program designed to replicate the strongly positive PAX-D study results and support a streamlined path to registration. TRD is estimated to affect up to 7 million adults in the U. businesswire.com - 2026-04-21 08:03:00 |
|
Alto Ingredients vs. Gevo: Which Renewable Energy Stock Wins?
ALTO is pivoting from commodity ethanol to specialty alcohols, carbon capture and 45Z credits-driving shares up 71.6% year to date. zacks.com - 2026-04-17 15:11:09 |